These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24089139)

  • 1. Knockdown of β-catenin with dicer-substrate siRNAs reduces liver tumor burden in vivo.
    Dudek H; Wong DH; Arvan R; Shah A; Wortham K; Ying B; Diwanji R; Zhou W; Holmes B; Yang H; Cyr WA; Zhou Y; Shah A; Farkiwala R; Lee M; Li Y; Rettig GR; Collingwood MA; Basu SK; Behlke MA; Brown BD
    Mol Ther; 2014 Jan; 22(1):92-101. PubMed ID: 24089139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct Pharmacological Inhibition of β-Catenin by RNA Interference in Tumors of Diverse Origin.
    Ganesh S; Koser ML; Cyr WA; Chopda GR; Tao J; Shui X; Ying B; Chen D; Pandya P; Chipumuro E; Siddiquee Z; Craig K; Lai C; Dudek H; Monga SP; Wang W; Brown BD; Abrams MT
    Mol Cancer Ther; 2016 Sep; 15(9):2143-54. PubMed ID: 27390343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma.
    Lin HH; Feng WC; Lu LC; Shao YY; Hsu CH; Cheng AL
    Cancer Lett; 2016 Oct; 381(1):58-66. PubMed ID: 27431312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Dicer Knockout on RNA Interference Using Various Dicer Substrate Small Interfering RNA (DsiRNA) Structures.
    Song MS; Alluin J; Rossi JJ
    Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interference with the expression of β-catenin reverses cisplatin resistance in A2780/DDP cells and inhibits the progression of ovarian cancer in mouse model.
    Zhao H; Wei W; Sun Y; Gao J; Wang Q; Zheng J
    DNA Cell Biol; 2015 Jan; 34(1):55-62. PubMed ID: 25211326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor Effect of Oleoyl-siRNA against Pancreatic Cancer Using a Portal Vein Infusion Liver-Metastatic Mouse Model.
    Kubo T; Yanagihara K; Nishimura Y; Iino Y; Komatsu T; Tansou R; Mihara K; Seyama T
    Mol Pharm; 2024 Oct; 21(10):5115-5125. PubMed ID: 39279440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro RNA interference against beta-catenin inhibits the proliferation of pediatric hepatic tumors.
    Sangkhathat S; Kusafuka T; Miao J; Yoneda A; Nara K; Yamamoto S; Kaneda Y; Fukuzawa M
    Int J Oncol; 2006 Mar; 28(3):715-22. PubMed ID: 16465377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of siRNA payloads to target KRAS-mutant cancer.
    Yuan TL; Fellmann C; Lee CS; Ritchie CD; Thapar V; Lee LC; Hsu DJ; Grace D; Carver JO; Zuber J; Luo J; McCormick F; Lowe SW
    Cancer Discov; 2014 Oct; 4(10):1182-1197. PubMed ID: 25100204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer.
    Renard CA; Labalette C; Armengol C; Cougot D; Wei Y; Cairo S; Pineau P; Neuveut C; de Reyniès A; Dejean A; Perret C; Buendia MA
    Cancer Res; 2007 Feb; 67(3):901-10. PubMed ID: 17283120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement.
    Tabernero J; Shapiro GI; LoRusso PM; Cervantes A; Schwartz GK; Weiss GJ; Paz-Ares L; Cho DC; Infante JR; Alsina M; Gounder MM; Falzone R; Harrop J; White AC; Toudjarska I; Bumcrot D; Meyers RE; Hinkle G; Svrzikapa N; Hutabarat RM; Clausen VA; Cehelsky J; Nochur SV; Gamba-Vitalo C; Vaishnaw AK; Sah DW; Gollob JA; Burris HA
    Cancer Discov; 2013 Apr; 3(4):406-17. PubMed ID: 23358650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Centyrin ligands for extrahepatic delivery of siRNA.
    Klein D; Goldberg S; Theile CS; Dambra R; Haskell K; Kuhar E; Lin T; Parmar R; Manoharan M; Richter M; Wu M; Mendrola Zarazowski J; Jadhav V; Maier MA; Sepp-Lorenzino L; O'Neil K; Dudkin V
    Mol Ther; 2021 Jun; 29(6):2053-2066. PubMed ID: 33601052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
    Ma L; Wang X; Jia T; Wei W; Chua MS; So S
    Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLR4 Influences Hepatitis B Virus Related Hepatocellular Carcinoma by Regulating the Wnt/β-Catenin Pathway.
    Yin Y; Li F; Li S; Cai J; Shi J; Jiang Y
    Cell Physiol Biochem; 2017; 42(2):469-479. PubMed ID: 28578348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simplified and versatile system for the simultaneous expression of multiple siRNAs in mammalian cells using Gibson DNA Assembly.
    Deng F; Chen X; Liao Z; Yan Z; Wang Z; Deng Y; Zhang Q; Zhang Z; Ye J; Qiao M; Li R; Denduluri S; Wang J; Wei Q; Li M; Geng N; Zhao L; Zhou G; Zhang P; Luu HH; Haydon RC; Reid RR; Yang T; He TC
    PLoS One; 2014; 9(11):e113064. PubMed ID: 25398142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effect of palmitic acid-conjugated DsiRNA for colon cancer in a mouse subcutaneous tumor model.
    Kubo T; Nishimura Y; Hatori Y; Akagi R; Mihara K; Yanagihara K; Seyama T
    Chem Biol Drug Des; 2019 Apr; 93(4):570-581. PubMed ID: 30560565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene silencing of beta-catenin by RNAi inhibits cell proliferation in human esophageal cancer cells in vitro and in nude mice.
    Wang JS; Zheng CL; Wang YJ; Wen JF; Ren HZ; Liu Y; Jiang HY
    Dis Esophagus; 2009; 22(2):151-62. PubMed ID: 19021690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition.
    Quan H; Zhou F; Nie D; Chen Q; Cai X; Shan X; Zhou Z; Chen K; Huang A; Li S; Tang N
    Oncogene; 2014 May; 33(22):2826-35. PubMed ID: 23770846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells.
    Qin X; Zhang H; Zhou X; Wang C; Zhang H; Zhang X; Ye L
    Transl Res; 2007 Nov; 150(5):281-94. PubMed ID: 17964517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational design and in vitro and in vivo delivery of Dicer substrate siRNA.
    Amarzguioui M; Lundberg P; Cantin E; Hagstrom J; Behlke MA; Rossi JJ
    Nat Protoc; 2006; 1(2):508-17. PubMed ID: 17406276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
    Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.